ClinicalTrials.gg
Not yet recruitingNCT06479850Updated Jul 24, 2024

A Strength-Based Intervention to Improve Job Interview Skills in Neurodiverse Young Adults

An interventional study of KF-STRIDE® in ADHD, Dyslexia and Learning Disabilities, sponsored by Kessler Foundation. Not yet recruiting. Open to participants aged 14 Years to 26 Years. Per ClinicalTrials.gov, last updated 2024-07-24.

Sponsored by Kessler Foundation · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Jun 2025, 1 year 5 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
14 Years to 26 Years
Sex
All
01

Study summary

the investigators are looking to evaluate the effectiveness of a strength-based program in improving job interview skills in neurodiverse young adults. This program is designed to help participants understand and speak to others about their personal qualities and abilities. The investigators are examining the effects of this program in young adults who may have difficulty with job interviews, and who may want to improve these skills. Some of these young adults have received special education services in the past for learning differences, such as attention deficit hyperactivity disorder (ADHD) or dyslexia.

Read the detailed description

Practicing job interview skills has been identified as an important target for job employment services in N-TAY. However, the majority of studies using interventions in neurodiverse individuals have taken a deficit-based approach (i.e. to fix what is deficient in a person). This approach has triggered increasing criticism and dissatisfaction from the disability community. Further, focusing on deficits will not result in identification, awareness, or expression of strengths, important skills needed for self-advocacy and transition to adulthood. KF-STRIDE takes a strength-based approach, using principles of positive psychology to help N-TAY identify and express their unique character strengths to future employers. Over the course of a recently funded pilot study, the team has evaluated the efficacy of KF-STRIDE in those on the autism spectrum. The investigators have found that individuals on the spectrum who train with KF-STRIDE show improved job interview skills, and preliminary data indicates that they also have improved chances of obtaining employment in the community. However, KF-STRIDE has never been evaluated in youth other than those on the spectrum, including those with ADHD, dyslexia or other learning differences which may benefit from the training. The investigators aim to evaluate the preliminary effectiveness of KF-STRIDE in a randomized controlled trial comparing KF-STRIDE to services as usual (SAU) to improve employment, as well as identify mechanistic targets which may lead to improved employment, and to evaluate the fidelity, acceptability, usability, and feasibility of the proposed intervention, KF-STRIDE, via initial process evaluation.

02

Conditions studied

03

In context

Attention Deficit Disorder with Hyperactivity

1,817 studies on the registry are indexed under Attention Deficit Disorder with Hyperactivity; 296 are open to participants now.

This study's planned enrollment of 50 is below the median of 71 across 1,437 interventional studies indexed under Attention Deficit Disorder with Hyperactivity.

Browse Attention Deficit Disorder with Hyperactivity studies →

Lead sponsor

Kessler Foundation is the lead sponsor of 175 studies on the registry; 61 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
14 Years to 26 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Lives in the United States of America
  • Between the ages of 14-26 Speaks English well
  • At a 4th grade reading level

Exclusion criteria

Exclusion Criteria:

  • Had a stroke, Traumatic Brain Injury, or neurological injury or disease in the past(like brain tumor or epilepsy)
  • Has a history of significant psychiatric illness(like schizophrenia or psychosis)
  • Has uncontrolled seizures or other unstable medical complications
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Treatment Group

    In this arm, participants would participate in in an intervention program that uses character strengths to improve job maintenance skills in young adults.

    Behavioral: KF-STRIDE®

  • No intervention
    Control Group

    In this arm, participants are services as usual and will participate in their regular activities.

Interventions

  • BehavioralKF-STRIDE®

    Treatment group will receive 12 web based sessions of a strength-based training tool (once or twice a week). Sessions are approximately 60 minutes long.

    Also known as: Kessler Foundation Strength Identification and Expression

06

What researchers measure

Primary outcomes

  1. Mock Job Interview

    Blinded reviewers using a standardized scoring measure will rate the video recorded mock job interviews, where the minimum total value is a 0 and the maximum total value is 77, with higher scores meaning a better outcome.

    Time frame: [Time Frame: Baseline, Immediate Post-Test between weeks 7 and 8]

  2. Employment Status

    We will examine whether the person became employed or other changes to their employment status. Yes=1, No=0

    Time frame: Baseline, Immediate Post-Test between weeks 7 and 8, and 6 months Post-Test

  3. Time-to-reach Employment

    We will examine how long it took for the person to obtain employment. Assessed as weeks since intervention completion.

    Time frame: 6 months Post-Test

  4. Strength Knowledge and Strengths Use Scale (SKUS)

    Measure to assess knowledge and use of one's strengths and measure changes following strengths-based interventions. Two scores: Strengths Use and Strengths Knowledge. Strengths Use values range from 14-98, with higher score indicating a better outcome. Strengths Knowledge values range from 8-56, with higher score indicating a better outcome

    Time frame: Baseline, Immediate Post-test between weeks 7 and 8

  5. Youth Interview- Self Efficacy and Anxiety

    25 items combined, about confidence and interview comfort in adolescents, with values ranging from 0 to 5 for each item, and higher scores meaning a better outcome.

    Time frame: Baseline, Immediate Post-test between weeks 7 and 8

  6. Job Search Behavior Scale

    12 items measuring how often one engages in job search activities- language modified for use in youth, with values ranging from 1-5, with higher scores meaning a better outcome.

    Time frame: Baseline, Immediate Post-test between weeks 7 and 8

  7. Work Readiness Scale

    13 items about the perception of one's ability to work, with values ranging from 1 to 5, with higher scores meaning a better outcome.

    Time frame: Baseline, Immediate Post-test between weeks 7 and 8

  8. Global Assessment of Character Strengths (GACS)

    24 items measuring one's identification of personal character strengths, with values ranging from 1 to 5, with higher scores meaning a better outcome

    Time frame: Baseline, Immediate Post-test between weeks 7 and 8

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 24, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06479850
Lead sponsor
Kessler Foundation
Responsible party
Sponsor
First posted
Jun 28, 2024
Start date
Aug 1, 2024 (estimated)
Primary completion
Jun 1, 2025 (estimated)
Completion
Dec 1, 2025 (estimated)
Last update
Jul 24, 2024

Study contacts

Helen Genova
Contact
hgenova@kesslerfoundation.org
973-324-8390
Katarina Reduzzi
Contact
kreduzzi@kesslerfoundation.org
Helen Genova
principal investigator · Kessler Foundation

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion